A 4-month rifampin regimen was found to be cheaper than a 9-month course of isoniazid for the treatment of latent tuberculosis in a cost-comparison study published in the Annals of Internal Medicine.

March 18, 2003 — Doctors should closely monitor patients treated with rifampin and pyrazinamide for latent tuberculosis, according to a report published in the March 15 issue of the American Journal ...

Background. Randomized controlled trials have demonstrated that the newest latent tuberculosis (LTBI) regimen, 12 weekly doses of directly observed isoniazid and rifapentine (3HP), is as efficacious ...

A newly recommended treatment for latent tuberculosis (TB) infection can cause liver injury, and therefore needs to be used with great caution and frequent monitoring, according to a UCSF-led, ...

The Centers for Disease Control and Prevention (CDC) estimates that up to 13 million people in the United States have latent tuberculosis (TB) infection. These patients do not feel sick, do not show ...

DENVER -- In patients with tuberculosis (TB), a novel fixed-dose combination of alpibectir-ethionamide had similar levels of bactericidal activity as isoniazid, with no serious adverse events and good ...

The CDC and National Tuberculosis Controllers Association, or NTCA, has published updated recommendations for latent tuberculosis, or LTBI, in the MMWR for the first time since 2000. To develop the ...

Isoniazid is the recommended treatment for latent tuberculosis infection, but its benefit is substantially reduced because of hepatotoxicity and poor rates of regimen completion. New research findings ...

ATS 2008, TORONTO—A new way to treat patients with latent tuberculosis (TB), who are infected with TB but without symptoms, can effectively treat it in less than half the time and at a lower cost than ...

The screening and treatment of latent tuberculosis infection (LTBI) to prevent active tuberculosis (TB) is recommended by the WHO in all HIV-infected patients. The aim of this study was to evaluate ...

Tuberculosis (TB) probably isn't at the top of your worry list like the flu, COVID, and norovirus are. After all, many people believe the disease has been all but eradicated in the U.S. As it turns ...